About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Multiple Sclerosis Clinical Trials in Chicago | 113 Studies

Clinical Trials Multiple SclerosisChicago

Multiple Sclerosis Clinical Trials in Chicago

Find 113 clinical trials for multiple sclerosis near Chicago, Illinois. Connect with research centers in your area.

All Multiple Sclerosis trials nationwide All trials in Chicago

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 41-60 of 113 trials

CompletedObservational Study of Tysabri in Early Relapsing-Remitting Multiple Sclerosis in Anti-JC Virus Antibody Negative ParticipantsThe primary objective of the study is to determine which baseline and yearly response factors (clinical and para clinical) predict overall disease-free status at Month 12 and…NCT01485003·Homewood, Alabama and 43 others

Multiple Sclerosis Trials in Other Cities

New York Los Angeles Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

RecruitingOcrevus Zunovo for MS: Mixed MethodsOcrevus Zunovo implementation, feasibility, acceptability, patient satisfaction, treatment persistence, and impact on MS disease outcomes will be analyzed in this mixed methods…NCT07710105·Chicago, Illinois

CompletedMechanism of Action of Ocrelizumab in Multiple SclerosisOcrelizumab is FDA approved for therapy of multiple sclerosis (MS). It depletes B cells and stops MS inflammation.NCT03344094·Chicago, Illinois

RecruitingStudy to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple SclerosisThe purpose of this study is to evaluate the effectiveness, safety, tolerability, drug levels and drug effects of ozanimod compared to fingolimod in children and adolescents with…NCT06408259·Loma Linda, California and 32 others

Not yet recruitingPhysical Activity Intervention for Individuals Newly Diagnosed With MSThe proposed study is a parallel-group randomized controlled trial (RCT) designed to establish the behavioral mechanism underlying a 16-week physical activity (PA) behavioral…NCT07731659·Chicago, Illinois

CompletedStudy of Fampridine-ER Tablets in Patients With Multiple SclerosisThe purpose of this study is to investigate the safety and efficacy of a lower dose of dalfampridine extended release tablets compared to the currently approved dose in improving…NCT01328379·Cullman, Alabama and 69 others

Active not recruitingLifestyle Physical Activity Intervention for Persons Newly Diagnosed With Multiple SclerosisThe overall objective of the current study is to determine the efficacy of a 16-week remotely delivered lifestyle behavioral intervention compared with a control condition (i.e.…NCT06355804·Chicago, Illinois

CompletedAcute Intermittent Hypoxia in Persons With Multiple SclerosisThe overall objective of this project is to investigate the effectiveness of Acute Intermittent Hypoxia (AIH), to improve muscle strength and activity level in individuals with…NCT04280484·Chicago, Illinois

CompletedExploring the Efficacy and Safety of Siponimod in Patients With Secondary Progressive Multiple Sclerosis (EXPAND)Evaluate the safety and efficacy of Siponimod (BAF312) versus placebo in a variable treatment duration in patients with secondary progressive multiple sclerosis (Core Part)…NCT01665144·Phoenix, Arizona and 289 others

Active not recruitingA Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple SclerosisThis is a Phase IIIb, single-arm, multicenter, OLE study.NCT05269004·Phoenix, Arizona and 235 others

CompletedOpen-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR in Patients With Multiple SclerosisThe purpose of this study is to evaluate the long-term safety, tolerability and activity of Fampridine-SR in subjects with multiple sclerosis who have previously participated in…NCT00654927·Phoenix, Arizona and 21 others

RecruitingEffects of Acute Intermittent Hypoxia on Neuroplasticity in MSThis study seeks to explore changes in the neural pathways and arm function following a breathing intervention in the multiple sclerosis (MS) population.NCT06390930·Chicago, Illinois

TerminatedEvaluation of the Effect of Nabiximols Oromucosal Spray on Clinical Measures of Spasticity in Participants With Multiple SclerosisThis study will be conducted to evaluate the effect of multiple doses of nabiximols compared with placebo on a clinical measure of velocity-dependent muscle tone in the lower…NCT04984278·Denver, Colorado and 29 others

CompletedSafety and Efficacy Study of Oral Fampridine-SR in Patients With Multiple SclerosisMultiple Sclerosis (MS) is a disorder of the body's immune system that affects the Central Nervous System (CNS).NCT00053417·Phoenix, Arizona and 24 others

RecruitingPeople With Multiple Sclerosis Treated With Ocrelizumab and GLP-1 AgonistsThe primary outcome measure is PIRA (progression independent of relapse activity), based primarily on clinical assessment, dichotomized as present or not.NCT07207148·Chicago, Illinois

Active not recruitingThe Synergistic Effects of AIH and FES in Persons With MSThe purpose of this study is to examine how neuromuscular electrical stimulation (NMES), may synergistically enhance corticospinal excitability in people with relapsing form…NCT06413602·Chicago, Illinois

CompletedThe Efficacy, Safety, and Tolerability of Laquinimod in Participants With Relapsing Remitting Multiple Sclerosis (RRMS)This is a multinational, multicenter, randomized, double-blind, parallel-group, placebo-controlled study followed by active treatment, to evaluate the efficacy, safety and…NCT01707992·Cullman, Alabama and 283 others

CompletedSafety and Efficacy of AVP-923 in PBA Patients With ALS or MSObjectives of the study are to evaluate the safety, tolerability, and efficacy of two different doses of AVP-923 (capsules containing either 30 mg of dextromethorphan hydrobromide…NCT00573443·Phoenix, Arizona and 61 others

CompletedEffectiveness of DMF and Its Impact on PROs in Suboptimal GA Responders With RMSThe primary objective of the study is to estimate the annualized relapse rate (ARR) over a 12-month period in patients with relapsing forms of multiple sclerosis (MS) who are…NCT01903291·Birmingham, Alabama and 61 others

RecruitingStudy to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of UblituximabThe primary purpose of this phase 3b study is to assess the efficacy of a modified regimen of ublituximab in participants with relapsing multiple sclerosis (RMS) as measured by T1…NCT05877963·Birmingham, Alabama and 50 others

PreviousPage 3 of 6Next

Other Conditions in Chicago

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia